<?xml version="1.0" encoding="UTF-8"?>
<ref id="R39">
 <label>39. </label>
 <mixed-citation publication-type="journal">
  <string-name>
   <surname>Li</surname>
   <given-names>W</given-names>
  </string-name>, 
  <string-name>
   <surname>Escarpe</surname>
   <given-names>PA</given-names>
  </string-name>, 
  <string-name>
   <surname>Eisenberg</surname>
   <given-names>EJ</given-names>
  </string-name>, 
  <string-name>
   <surname>Cundy</surname>
   <given-names>KC</given-names>
  </string-name>, 
  <string-name>
   <surname>Sweet</surname>
   <given-names>C</given-names>
  </string-name>, 
  <string-name>
   <surname>Jakeman</surname>
   <given-names>KJ</given-names>
  </string-name>, 
  <etal/>
  <article-title>Identification of GS 4104 as an orally bioavailable prodrug of the influenza virus neuraminidase inhibitor GS 4071.</article-title>
  <source>Antimicrob Agents Chemother</source>. 
  <year>1998</year>;
  <volume>42</volume>:
  <fpage>647</fpage>â€“
  <lpage>53</lpage>
  <pub-id pub-id-type="pmid">9517946</pub-id>
 </mixed-citation>
</ref>
